Instead of pharmacare, Canadians need faster drug-approval timelines

Patients in Canada wait longer than most of our peer countries to access fewer medicines.
First ministers' meeting
Provincial governments need to work with Ottawa to improve the drug approval and public reimbursement process, writes Liam MacDonald.

In October 2024, Ottawa’s national pharmacare legislation received royal assent. The federal government promptly began negotiations with the provinces to provide public coverage for diabetes and contraceptive drugs on a first-dollar, single-payer basis under the plan’s f...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES